OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Stock

Certificat

DE000GZ0LA20

Market Closed - BOERSE MUENCHEN 02:26:38 2024-06-14 pm EDT
1.983 EUR -1.59% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month-0.25%
1 month-3.13%
Date Price Change
24-06-14 1.983 -1.59%
24-06-13 2.015 -0.59%
24-06-12 2.027 +1.40%
24-06-11 1.999 -1.58%
24-06-10 2.031 +0.25%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GZ0LA2
ISINDE000GZ0LA20
Date issued 2022-09-23
Strike 40.64 $
Maturity Unlimited
Parity 25 : 1
Emission price 1.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.377
Lowest since issue 1.165

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
93.47 USD
Average target price
108.2 USD
Spread / Average Target
+15.71%
Consensus